Reuters Health Information (2007-11-19): Bayer's Nexavar gets U.S. FDA nod for liver cancer
Bayer's Nexavar gets U.S. FDA nod for liver cancer
Last Updated: 2007-11-19 14:23:41 -0400 (Reuters Health)
FRANKFURT (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Nexavar (sorafenib) to treat liver cancer, Bayer said on Monday.
Bayer already got approval from the European Commission to sell Nexavar for liver cancer treatment last month.
Nexavar is already approved in Europe and the United States for kidney cancer.
Bayer is developing the drug together with its U.S. partner Onyx Pharmaceuticals.